{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T00:29:39Z","timestamp":1784334579973,"version":"3.55.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern Emerg Med"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1007\/s11739-011-0668-6","type":"journal-article","created":{"date-parts":[[2011,10,18]],"date-time":"2011-10-18T17:10:24Z","timestamp":1318957824000},"page":"11-15","source":"Crossref","is-referenced-by-count":5,"title":["Pathogenetic, clinical and pharmaco-economic assessment in rheumatoid arthritis (RA)"],"prefix":"10.1007","volume":"6","author":[{"given":"Gianfranco","family":"Ferraccioli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Gremese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,10,19]]},"reference":[{"key":"668_CR1","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s11926-009-0050-0","volume":"11","author":"RM Plenge","year":"2009","unstructured":"Plenge RM (2009) Rheumatoid arthritis genetics: 2009 update. Curr Rheumatol Rep 11:351\u2013356","journal-title":"Curr Rheumatol Rep"},{"key":"668_CR2","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1136\/ard.2008.095414","volume":"68","author":"B Tolusso","year":"2009","unstructured":"Tolusso B, Frezza D, Mattioli C, Fedele AL, Bosello S, Faustini F, Peluso G, Giambra V, Pietrapertosa D, Morelli A, Gremese E, De Santis M, Ferraccioli GF (2009) Allele *2 of the HS1, 2 A enhancer of the Ig regulatory region associates with rheumatoid arthritis. Ann Rheum Dis 68:416\u2013419","journal-title":"Ann Rheum Dis"},{"key":"668_CR3","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1136\/ard.2010.137174","volume":"70","author":"G Orozco","year":"2011","unstructured":"Orozco G, Eyre S, Hinks A, Bowes J, Morgan AW, Wilson AG, Wordsworth P, Steer S, Hocking L, UKRAG consortium, Worthington J, Barton A (2011) Study of the common genetic background for rheumatoid arthritis and systemic lupus erythematosus. Ann Rheum Dis 70:463\u2013468","journal-title":"Ann Rheum Dis"},{"key":"668_CR4","doi-asserted-by":"crossref","first-page":"R135","DOI":"10.1186\/ar2553","volume":"10","author":"F Ria","year":"2008","unstructured":"Ria F, Penitente R, De Santis M, Nicolo\u2019 C, Di Sante G, Orsini M, Arzani D, Fattorossi A, Battaglia A, Ferraccioli GF (2008) Collagen-specific T cell repertoire in blood and synovial fluid varies with disease activity in early rheumatoid arthritis. Arthritis Res Therapy 10:R135","journal-title":"Arthritis Res Therapy"},{"issue":"7","key":"668_CR5","doi-asserted-by":"crossref","first-page":"e11550","DOI":"10.1371\/journal.pone.0011550","volume":"5","author":"MC Rosa De","year":"2010","unstructured":"De Rosa MC, Giardina B, Bianchi C, Carelli Alinovi C, Pirolli D, Ferraccioli GF, De Santis M, Di Sante G, Ria F (2010) Modeling the ternary complex TCR-Vbeta\/Collagen II (261\u2013273)\/HLA-DR4 associated with rheumatoid arthritis. PLoS ONE 5(7):e11550","journal-title":"PLoS ONE"},{"key":"668_CR6","unstructured":"Ria F et al. Unpublished"},{"key":"668_CR7","first-page":"552","volume":"1 6","author":"GF Ferraccioli","year":"2010","unstructured":"Ferraccioli GF, Bracci-Laudiero L, Alivernini S, Gremese E, Tolusso B, De Benedetti F (2010) Interleukin 1 \u03b2 and interleukin 6 in arthritis animal models: roles in the early phase of transition from acute to chronic inflammation and relevance for human rheumatoid arthritis. M O L M E D 1 6:552\u2013557","journal-title":"M O L M E D"},{"key":"668_CR8","first-page":"413","volume":"11","author":"GF Ferraccioli","year":"2011","unstructured":"Ferraccioli GF, Zizzo G (2011) The potential role of TH17 in mediating the transition from acute to chronic autoimmune inflammation: rheumatoid arthritis as a model. Discovery Medicine 11:413\u2013424","journal-title":"Discovery Medicine"},{"key":"668_CR9","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.clim.2010.10.002","volume":"138","author":"G Zizzo","year":"2011","unstructured":"Zizzo G, De Santis M, Bosello SL, Fedele AL, Peluso G, Gremese E, Tolusso B, Ferraccioli GF (2011) Synovial fluid-derived T helper 17 cells correlate with inflammatory activity in arthritis, irrespectively of diagnosis. Clin Immunol 138:107\u2013116","journal-title":"Clin Immunol"},{"key":"668_CR10","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/S0140-6736(94)90628-9","volume":"344","author":"MJ Elliott","year":"1994","unstructured":"Elliott MJ, Maini RN, Feldmann M, Kalden JR, Antoni C, Smolen JS, Leeb B, Breedveld FC, McFarlane JD (1994) Randomized double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha(cA2) in patients with rheumatoid arthritis. Lancet 344:1105\u20131110","journal-title":"Lancet"},{"key":"668_CR11","doi-asserted-by":"crossref","unstructured":"Tanimoto K, Iwabuchi Y, Tanne Y, Kamiya T, Inubushi T, Mitsuyoshi T, Tanne K (2011) Interleukin 1 beta affects cyclooxygenase 2 expression and cartilage metabolism in mandibular condyle. Arch Oral Biol [Epub ahead of print]","DOI":"10.1016\/j.archoralbio.2011.05.005"},{"key":"668_CR12","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1136\/ard.61.8.704","volume":"61","author":"PJ Koshy","year":"2002","unstructured":"Koshy PJ, Henderson N, Logan C, Life PF, Cawston TE, Rowan AD (2002) Interleukin 17 induces cartilage collagen breakdown: novel synergistic effects in combination with proinflammatory cytokines. Ann Rheum Dis 61:704\u2013713","journal-title":"Ann Rheum Dis"},{"key":"668_CR13","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/rheumatology\/34.4.321","volume":"34","author":"M Mihara","year":"1995","unstructured":"Mihara M, Moriya Y, Kishimoto T, Ohsugi Y (1995) Interleukin 6 induces the proliferation of synovial fibroblastic cells in the presence of soluble IL6 receptors. Br J Rheumatol 34:321\u2013325","journal-title":"Br J Rheumatol"},{"key":"668_CR14","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/jbmr.5650110113","volume":"11","author":"S Kotake","year":"1996","unstructured":"Kotake S, Sato K, Kim KJ, Takahashi N, Udagawa N, Nakamura I, Yamaguchi A, Kishimoto T, Suda T, Kashiwazaki S (1996) Interleukin-6 and soluble interleukin 6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast-like cell formation. J Bone Miner Res 11:88\u201395","journal-title":"J Bone Miner Res"},{"key":"668_CR15","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1002\/jcb.22476","volume":"109","author":"DP Trebec-Reynolds","year":"2010","unstructured":"Trebec-Reynolds DP, Voronov I, Heersche JN, Manolson MF (2010) IL1 alpha and IL1beta have different effects on formation and activity of large osteoclasts. J Cell Biochem 109:975\u2013982","journal-title":"J Cell Biochem"},{"key":"668_CR16","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.humimm.2009.01.023","volume":"70","author":"S Rutella","year":"2009","unstructured":"Rutella S, De Cristofaro R, Ferraccioli GF (2009) Function and dysfunction of dendritic cells in autoimmune rheumatic diseases. Human Immunol 70:360\u2013373","journal-title":"Human Immunol"},{"key":"668_CR17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/039463200702000101","volume":"20","author":"S Bosello","year":"2007","unstructured":"Bosello S, Pers JO, Rochas C, Devauchelle V, De Santis M, Daridon C, Saraux A, Ferraccioli GF, Youinou P (2007) BAFF and rheumatic autoimmune disorders: implications for disease management and therapy. Int J Immunopathol Pharmacol 20:1\u20138","journal-title":"Int J Immunopathol Pharmacol"},{"key":"668_CR18","first-page":"1256","volume":"35","author":"S Bosello","year":"2008","unstructured":"Bosello S, Youinou P, Daridon C, Tolusso B, Bendaoud B, Pietrapertosa D, Morelli A, Ferraccioli GF (2008) Concentrations of BAFF correlate with autoantibody levels, clinical disease activity and response to treatment in early rheumatoid arthritis. J Rheumatol 35:1256\u20131264","journal-title":"J Rheumatol"},{"key":"668_CR19","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.clim.2008.11.011","volume":"131","author":"B Tolusso","year":"2009","unstructured":"Tolusso B, De Santis M, Bosello S, Gremese E, Gobessi S, Cuoghi I, Rumi C, Efremov DG, Ferraccioli GF (2009) Synovial B cells of rheumatoid arthritis express Zap-70 which increases the survival and correlates with the inflammatory and autoimmune phenotypes. Clin Immunol 131:98\u2013108","journal-title":"Clin Immunol"},{"key":"668_CR20","doi-asserted-by":"crossref","unstructured":"Michelutti A, Gremese E, Morassi F, Petricca L, Arena V, Tolusso B, Alivernini S, Peluso G, Bosello SL, Ferraccioli GF (2011) B cell subsets in the joint compartments of seropositive and seronegative RA and non-RA arthritides express memory markers and Zap-70 and characterize the aggregate pattern irrespectively of the autoantibody status. Mol Med [Epub ahead of print]","DOI":"10.2119\/molmed.2011.00034"},{"key":"668_CR21","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1515\/CCLM.2010.152","volume":"48","author":"D Pietrapertosa","year":"2010","unstructured":"Pietrapertosa D, Tolusso B, Gremese E, Papalia MC, Bosello S, Peluso G, Petricca L, Michelutti A, Faustini F, Fedele AL, Ferraccioli GF (2010) Diagnostic performance of anti-citrullinated peptide antibodies for the diagnosis of rheumatoid arthritis: the relevance of the likelihood ratios. Clin Chem Lab Med 48:829\u2013834","journal-title":"Clin Chem Lab Med"},{"key":"668_CR22","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1002\/art.27580","volume":"62","author":"T Neogi","year":"2010","unstructured":"Neogi T et al (2010) The 2010 American College of Rheumatology\/European League against Rheumatism classification criteria for rheumatoid arthritis. Phase 2 methodological report. Arthritis Rheum 62:2582\u20132591","journal-title":"Arthritis Rheum"},{"key":"668_CR23","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/S0140-6736(99)05246-0","volume":"354","author":"RN Maini","year":"1999","unstructured":"Maini RN, StClair EW, Breedveld F, Furst D, Kalden J, Weisman M, Smolen J, Emery P, Feldmann M, Lipsky P (1999) Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomized phase III trial. ATTRACT Study Group. Lancet 354:1932\u20131939","journal-title":"Lancet"},{"key":"668_CR24","doi-asserted-by":"crossref","unstructured":"Maini RN, Taylor PC, Szechinski J, Pavelka K, Broll J, Balint G, Emery P, Raemen F, Petersen J, Smolen J, Thomson D, Kishimoto T, the CHARISMA Study Group (2006) Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate. Arthritis Rheum 54:2817\u20132829","DOI":"10.1002\/art.22033"},{"key":"668_CR25","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1002\/art.27692","volume":"62","author":"MPM Linden Van der","year":"2010","unstructured":"Van der Linden MPM, Le Cessie S, Raza K, Van der Woude D, Knevel R, Huizinga TW, Van der Helm-Van Mil AH (2010) Long-term impact of delay in assessment of patients with early arthritis. Arthritis Rheum 62:3537\u20133546","journal-title":"Arthritis Rheum"},{"key":"668_CR26","doi-asserted-by":"crossref","unstructured":"Vermeer M, Kuper HH, Hoekstra M, Haagsma CJ, Posthumus MD, Brus HL, Van Riel PL, Vam de Laar MA (2011) Implementation of a treat to target strategy in very early rheumatoid arthritis: results of the DREAM remission induction cohort. Arthritis Rheum 63 [Epub ahead of print]","DOI":"10.1002\/art.30494"},{"key":"668_CR27","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1136\/ard.2010.142729","volume":"70","author":"S Bosello","year":"2011","unstructured":"Bosello S, Fedele AL, Peluso G, Gremese E, Tolusso B, Ferraccioli GF (2011) Very early rheumatoid arthritis is the major predictor of major outcomes: clinical ACR remission and radiographic non- progression. Ann Rheum Dis 70:1292\u20131295","journal-title":"Ann Rheum Dis"},{"key":"668_CR28","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1136\/ard.2010.129924","volume":"70","author":"G Peluso","year":"2011","unstructured":"Peluso G, Michelutti A, Bosello S, Gremese E, Tolusso B, Ferraccioli GF (2011) Clinical and ultrasonographic remission determines different chances of relapse in early and long standing rheumatoid arthritis. Ann Rheum Dis 70:172\u2013175","journal-title":"Ann Rheum Dis"},{"key":"668_CR29","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1080\/03009740601061126","volume":"35","author":"G Kobelt","year":"2006","unstructured":"Kobelt G (2006) Health economic issues in rheumatoid arthritis. Scand J Rheumatol 35:415\u2013425","journal-title":"Scand J Rheumatol"},{"key":"668_CR30","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0140-6736(08)61000-4","volume":"372","author":"P Emery","year":"2008","unstructured":"Emery P, Breedvel FC, Hall S, Durez P, Chang DJ, Robertson D, Singh A, Pedersen MD, Koenig AS, Freundlich B (2008) Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial. Lancet 372:375\u2013382","journal-title":"Lancet"},{"key":"668_CR31","first-page":"1875","volume":"32","author":"F Wolfe","year":"2005","unstructured":"Wolfe F, Michaud K, Choi HK, Williams R (2005) Household income and earnings losses among 6,396 persons with rheumatoid arthritis. J Rheumatol 32:1875\u20131883","journal-title":"J Rheumatol"}],"container-title":["Internal and Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-011-0668-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11739-011-0668-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-011-0668-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,13]],"date-time":"2024-04-13T21:03:26Z","timestamp":1713042206000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11739-011-0668-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":31,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["668"],"URL":"https:\/\/doi.org\/10.1007\/s11739-011-0668-6","relation":{},"ISSN":["1828-0447","1970-9366"],"issn-type":[{"value":"1828-0447","type":"print"},{"value":"1970-9366","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}